Your labs are "normal" but you feel terrible.

A common clinical scenario.

It goes something like this. You're 47. Maybe 52. Something shifted. Sleep became unreliable. Your weight started accumulating around your midsection despite no change in diet or exercise. Your brain feels slower. Your mood is unpredictable. Your joints hurt. Your libido disappeared.

You went to your doctor. They ran labs. Maybe a CBC, a metabolic panel, thyroid. Everything came back "normal." Your doctor said you're fine. Maybe suggested better sleep hygiene. Maybe offered an antidepressant.

You're not fine. And you know it.

Why "normal" doesn't mean what you think.

Lab reference ranges are built from population data. They represent the range of values found in a large sample of people — including people who are symptomatic, people of all ages, and people whose levels happen to fall at the extremes but weren't flagged as abnormal.

For reproductive hormones in women, the ranges are even less useful because they fluctuate dramatically through the menstrual cycle, perimenopause, and menopause. A "normal" estradiol level for a 25-year-old mid-cycle is completely different from a "normal" level for a 50-year-old in late perimenopause. But the reference range on the lab report often doesn't distinguish between the two.

More importantly: menopause is primarily a clinical diagnosis, not a lab diagnosis. The American College of Obstetricians and Gynecologists has stated that hormone testing is generally not necessary to diagnose menopause or perimenopause in women with characteristic symptoms and the appropriate age. Levels fluctuate too much during the transition to be reliably diagnostic.

In other words, your doctor should be listening to your symptoms and your timeline, not waiting for a lab value to cross an arbitrary line.

What I actually evaluate.

When a woman comes to me with symptoms suggestive of perimenopause or menopause, the conversation matters more than any single lab result. I'm asking:

• Symptom timeline. When did things change? Was it gradual or sudden? Is it getting worse? Are there patterns?
• Menstrual history. Cycle changes — irregular periods, heavier or lighter flow, missed cycles — are often the earliest sign of the perimenopausal transition, sometimes years before classic symptoms like hot flashes appear.
• Sleep quality. Not just "are you sleeping" but the architecture of sleep — sleep-maintenance insomnia is common during the menopause transition and can have multiple contributors.
• Vasomotor symptoms. Hot flashes and night sweats are the most recognizable symptoms, but many women experience subtler temperature dysregulation — feeling warmer than usual, flushing that they don't connect to menopause.
• Cognitive changes. "Brain fog" is real. Estrogen receptors exist throughout the brain. Declining estrogen affects memory, concentration, and word retrieval. These symptoms are frequently dismissed or attributed to stress.
• Mood and anxiety. New mood or anxiety symptoms can occur during the menopause transition, but other causes should also be considered. A careful evaluation before prescribing is important.
• Body composition. Menopause and aging can affect body composition and fat distribution, while nutrition, physical activity, sleep, medications and other factors also play a role.
• Family history. When did your mother go through menopause? Any history of breast cancer, blood clots, cardiovascular disease? These inform both the diagnosis and the treatment risk-benefit analysis.

When labs are useful — and when they're not.

I'm not against lab testing. I order it when it adds clinical value. But I'm specific about what I order and why.

When labs help

• When the diagnosis is unclear — is this perimenopause, thyroid dysfunction, or something else?
• When I need to evaluate thyroid function, which can mimic or compound menopausal symptoms
• When establishing a hormonal baseline before starting treatment
• When monitoring treatment safety (e.g., lipids, liver function) and assessing symptom response
• When a patient is younger than typical (under 40) and premature ovarian insufficiency is a concern

When labs are misleading

• In perimenopause, hormone levels can swing dramatically week to week. A single FSH or estradiol level drawn on a random Tuesday can be "normal" and completely unrepresentative of what's happening over time.
• Standard lab panels don't include hormones. If your doctor ran a "full panel" and told you everything's fine, they probably didn't check estradiol, progesterone, FSH, or free testosterone.
• Reference ranges are too broad to be clinically meaningful for hormonal symptoms. A woman with an estradiol of 35 pg/mL may be "within range" but profoundly symptomatic.

The diagnosis is you, not your lab slip.

This is the part that gets lost in the system. A woman with characteristic symptoms at the right age, with a consistent timeline and no alternate explanation, has a clinical diagnosis. She doesn't need a lab value to validate what she's experiencing.

Labs are useful for ruling out other causes (thyroid, anemia, metabolic dysfunction) and for safety monitoring once treatment starts. For standard menopausal hormone therapy, symptom response and safety monitoring generally matter more than chasing specific hormone levels. The labs are not the gatekeeper to care. Your symptoms are.

If a physician listens to your history, takes your symptoms seriously, evaluates the timeline, considers the differential, and then discusses treatment options based on the full clinical picture — that's how this is supposed to work.

If a physician runs a random hormone level, says "normal," and sends you home — that's not an evaluation. That's a missed opportunity.

What actually helps.

Menopausal hormone therapy — estrogen, often with progesterone, and sometimes with testosterone — remains the most effective treatment for vasomotor symptoms, sleep disruption, and many of the other symptoms of menopause. The evidence supporting its use in appropriate candidates is strong and has only grown in the years since the initial WHI results were reinterpreted.

But "appropriate candidates" matters. The decision to start hormone therapy involves your symptom severity, your age and time since menopause, your cardiovascular risk profile, your family history, your personal risk factors, and your treatment goals. This is an individualized conversation, not a protocol.

That conversation is exactly what I do at Wellesley Medical. And it starts with listening.

References.

• American College of Obstetricians and Gynecologists. Practice Bulletin No. 141: Management of Menopausal Symptoms. Obstet Gynecol. 2014 (reaffirmed 2023).
• The Menopause Society (formerly NAMS). The 2022 Hormone Therapy Position Statement of The North American Menopause Society. Menopause. 2022;29(7):767-794.